ANI Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on ANI Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how ANI Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with ANI Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on ANI Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20220184094A1 | Application | HYDROCHLOROTHIAZIDE COMPOSITIONS | A61K31/549; A61K47/12; A61K47/26; A61K47/36 | June 16, 2022 |
| US20220047508A1 | Application | STABLE ORAL LIQUID COMPOSITION OF TERAZOSIN | A61K31/517; A61K47/10; A61K47/26; A61K9/0053; A61K9/08 | February 17, 2022 |
| US11224572B1 | Grant | Stable oral liquid composition of terazosin | A61K31/517; A61K47/10; A61K47/26; A61K9/0053; A61K9/08 | January 18, 2022 |
| US20170232002A1 | Application | COMMERCIAL SCALE PRODUCTION METHODS FOR TRANSDERMAL HORMONE FORMULATIONS | A61K31/565; A61K31/566; A61K31/568; A61K31/57; A61K47/10; A61K47/18; A61K47/183; A61K47/32; A61K9/0014; A61P15/00 | August 17, 2017 |
| US20170128462A1 | Application | METHODS FOR TREATING FEMALE SEXUAL DYSFUNCTION WHILE DECREASING CARDIOVASCULAR RISK | A61K31/568; A61K31/569; A61K31/585; A61K47/02; A61K47/10; A61K47/14; A61K47/32; A61K9/0014; A61K9/06; A61P15/00 | May 11, 2017 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer